Status:
COMPLETED
Late Potentials and Ablation Index in Ventricular Tachycardia Ablation
Lead Sponsor:
University Hospital Southampton NHS Foundation Trust
Collaborating Sponsors:
Biosense Webster, Inc.
Conditions:
Ventricular Tachycardia
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
There is an increasing evidence regarding the efficacy of a substrate-based ablation approach to ventricular tachycardia (VT). This approach involves identifying regions of scar and also areas display...
Detailed Description
The study would propose to use the Carto3 mapping system with the Confidense automated tagging module (Biosense Webster Inc.,) and a high density mapping catheter to generate substrate maps of the ven...
Eligibility Criteria
Inclusion
- Ventricular Tachycardia; scheduled for ablation on clinical grounds; able/willing to consent to procedure/research protocol; no contraindication to clinical ablation; ≥18 years old
Exclusion
- Unable/unwilling to consent; contraindication to clinical ablation
Key Trial Info
Start Date :
June 26 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 22 2020
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT03437408
Start Date
June 26 2019
End Date
October 22 2020
Last Update
September 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Southampton General Hospital
Southampton, Hampshire, United Kingdom, SO16 6YD